Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gross

Showing results (891-900 of 976) with videos related to

Pageof 98
Sort By:
Head & Neck|August 11, 2020
Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomesAlexander F Bagley, Adam S Garden, Jay P Reddy, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 1, 2023
Outcomes for 160 Consecutive Lateral Arm Free Flaps for Head and Neck ReconstructionKevin J Contrera, Abbas M Hassan, John W Shuck, et al.
Plos Pathogens|January 10, 2013
Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3GDavid J Stanley, Koen Bartholomeeusen, David C Crosby, et al.
Oral Oncology|March 30, 2017
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatmentYuehan Zhang, Tim Waterboer, Robert I Haddad, et al.
Cancer Causes & Control : CCC|July 25, 2015
The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristicsHamed Samavat, Allison M Dostal, Renwei Wang, et al.
International Journal of Particle Therapy|July 21, 2021
Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of LifeAlexander D Sherry, Dario Pasalic, G Brandon Gunn, et al.
Plos Pathogens|September 12, 2022
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 proteinMarius Walter, Irene P Chen, Albert Vallejo-Gracia, et al.
JCO Precision Oncology|June 7, 2023
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck CancerHannah Y Chen, Weilu Zhao, Shorook Na'ara, et al.
International Journal of Particle Therapy|July 21, 2021
Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx CancerHouda Bahig, Brandon G Gunn, Adam S Garden, et al.
Journal of Medicinal Chemistry|February 18, 2005
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterizationFabio C Tucci, Yun-Fei Zhu, R Scott Struthers, et al.
Pageof 98

Showing results (891-900 of 976) with videos related to

Sort By:
Pageof 98
Head & Neck|August 11, 2020
Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomesAlexander F Bagley, Adam S Garden, Jay P Reddy, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 1, 2023
Outcomes for 160 Consecutive Lateral Arm Free Flaps for Head and Neck ReconstructionKevin J Contrera, Abbas M Hassan, John W Shuck, et al.
Plos Pathogens|January 10, 2013
Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3GDavid J Stanley, Koen Bartholomeeusen, David C Crosby, et al.
Oral Oncology|March 30, 2017
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatmentYuehan Zhang, Tim Waterboer, Robert I Haddad, et al.
Cancer Causes & Control : CCC|July 25, 2015
The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristicsHamed Samavat, Allison M Dostal, Renwei Wang, et al.
International Journal of Particle Therapy|July 21, 2021
Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of LifeAlexander D Sherry, Dario Pasalic, G Brandon Gunn, et al.
Plos Pathogens|September 12, 2022
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 proteinMarius Walter, Irene P Chen, Albert Vallejo-Gracia, et al.
JCO Precision Oncology|June 7, 2023
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck CancerHannah Y Chen, Weilu Zhao, Shorook Na'ara, et al.
International Journal of Particle Therapy|July 21, 2021
Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx CancerHouda Bahig, Brandon G Gunn, Adam S Garden, et al.
Journal of Medicinal Chemistry|February 18, 2005
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterizationFabio C Tucci, Yun-Fei Zhu, R Scott Struthers, et al.
Pageof 98